Comparison of SARS-CoV-2 seroprevalence estimates between commercial lab serum specimens and blood donor specimens, United States, September–December 2021

ABSTRACT We estimated monthly cross-sectional seroprevalence rates of anti-nucleocapsid (anti-N) and anti-spike (anti-S) antibodies to severe acute respiratory syndrome coronavirus 2 in two U.S. nationwide studies. The nationwide blood donor seroprevalence (NBDS) study included specimens from blood...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Szu-Yu Zoe Kao, Elise Nycz, Tina J. Benoit, Kristie E. N. Clarke, Jefferson M. Jones
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology 2024-08-01
Colecção:	Microbiology Spectrum
Assuntos:	SARS-CoV-2 anti-nucleocapsid antibody anti-spike antibody blood donors commercial laboratory
Acesso em linha:	https://journals.asm.org/doi/10.1128/spectrum.00123-24
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!